Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of Magnetic Resonance Imaging : JMRI|February 17, 2023
Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease StudyJoshua R Astley, Alberto M Biancardi, Paul J C Hughes, et al.
Nature Communications|November 16, 2019
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertensionNadine D Arnold, Josephine A Pickworth, Laura E West, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
Pulmonary Circulation|March 19, 2024
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologiesFrances Varian, Jennifer Dick, Christian Battersby, et al.
The European Respiratory Journal|July 26, 2024
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studiesS Ashwin Reddy, Joseph Newman, Olivia C Leavy, et al.
Cell Metabolism|December 11, 2020
Neutrophils Fuel Effective Immune Responses through Gluconeogenesis and GlycogenesisPranvera Sadiku, Joseph A Willson, Eilise M Ryan, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
Pageof 10